Replies to post #123572 on Biotech Values

[DewDiligence]

Re: NVS activity in China (and other emerging markets)

Here’s your answer (from #msg-49563901):

Novartis AG will expand its research and sales force in China with its own employees, its chief executive officer said in an interview, despite a trend in the industry toward outsourcing in China…

"It should be a strategy owned by Novartis and directed by Novartis," said Joe Jimenez, who became the Swiss drug maker's chief executive in a sweeping February restructuring. Mr. Jimenez reiterated the company's four-year, $1 billion plan for a six-building research campus in Shanghai that could ultimately employ 500 scientists.

Also see #msg-27259204, which is dated but still germane.